Association between serum resistin level and cardiovascular events in postmenopausal women with acute coronary syndrome undergoing percutaneous coronary intervention

Chinese Medical Journal

Volumn 126, Issue 6, 2013, Pages 1058-1062

  Lei, Li ^a,b   Han, Jiang Li ^a,b   Mao, Jie Ming ^a,b   Guo, Li Jun ^a,b   Wei, Gao ^a,b  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Acute coronary syndrome; Major adverse cardiovascular events; Postmenopausal women; Resistin

Indexed keywords

C REACTIVE PROTEIN; ESTROGEN; GLUCOSE; INSULIN; LIPID; RESISTIN;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; POSTMENOPAUSE; SURVIVAL;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, BALLOON, CORONARY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; POSTMENOPAUSE; RESISTIN;

EID: 84876897900     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20123548     Document Type: Article

References (26)

1. Odgerel T, Han JL, Yang CS, Mao JM. The relationship between sex hormones and extent of coronary artery disease in postmenopausal women. Chin Med J 2007; 120: 71-73.
2. Maas AH, van der Schouw YT, Regitz-Zagrosek V, Swahn E, Appelman YE, Pasterkamp G, et al. Red alert for women's heart: the urgent need for more research and knowledge on cardiovascular disease in women: proceedings of the workshop held in Brussels on gender differences in cardiovascular disease. Eur Heart J 2011; 32: 1362-1368.
3. Fargnoli JL, Sun Q, Olenczuk D, Qi L, Zhu Y, Hu FB, et al. Resistin is associated with biomarkers of inflammation while total and high molecular weight adiponectin are associated with biomarkers of inflammation, insulin resistance, and endothelial function. Eur J Endocnnol 2010; 162: 281-288.
4. Jung HS, Park KH, Cho YM, Chung SS, Cho HJ, Cho SY, et al. Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc Res 2006; 69: 76-85.
5. Braunwald E, Antman EM, Beasley JW, Cahff RM, Cheitlin MD, Hochman JS, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the Amencan College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol 2002; 40: 1366-1374.
6. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al; ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2004; 110: e82-e292.
7. Metabolic Syndrome Research Cooperation Group of Chinese Medical Association Diabetes Branch. Suggestion on metabolism syndrome 2004. Chin J Diabetes (Chin) 2004; 12: 156-161.
8. American Diabetes Association, Clinical practice recommendations 2005. Diabetes Care 2005; 28 Suppl: s1-s79.
9. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402-2410.
10. van Haeften TW. Glucose tolerance, insulin sensitivity, and the homeostasis model assessment method. Diabetes Care 1998; 21: 673-674.
11. Al-Khalili F, Svane B, Wamala SP, Orth-Gomér K, Rydén L, Schenck-Gustafsson K. Clinical importance of risk factors and exercise testing for prediction of significant coronary artery stenosis in women recovering from unstable coronary artery disease: the Stockholm Female Coronary Risk Study. Am Heart J 2000; 139: 971-978.
12. Pischon T, Bamberger CM, Kratzsch J, Zyriax BC, Algenstaedt P, Boeing H, et al. Association of plasma resistin levels with coronary heart disease in women. Obes Res 2005; 13: 1764-1771.
13. Kreçki R, Krzemmska-Pakuła M, Peruga JZ, Szczesniak P, Lipiec P, Wierzbowska-Drabik K, et al. Elevated resistin opposed to adiponectin or angiogenin plasma levels as a strong, independent predictive factor for the occurrence of major adverse cardiac and cerebrovascular events in patients with stable mutilvessel coronary artery disease over 1-year follow-up. Med Sci Monit 2011; 17: CR26-CR32.
14. Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 2003; 300: 472-476.
15. Festa A, D'Agostino Jr R, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42-47.
16. Momiyama Y, Ohmori R, Uto-Kondo H, Tanaka N, Kato R, Taniguchi H, et al. Serum resistin levels and cardiovascular events in patients undergoing percutaneous coronary intervention. J Atheroscler Thromb 2011; 18: 108-114.
17. Ohmon R, Momiyama Y, Kato R, Taniguchi H, Ogura M, Ayaon M, et al. Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. J Am Coll Cardiol 2005; 46: 379-380.
18. Chu S, Ding W, Li K, Pang Y, Tang C Plasma resistin associated with myocardium injury in patients with acute coronary syndrome. Circ J2008; 72: 1249-1253.
19. Odgerel T, Han JL, Mao JM. Association of serum resistin levels with the seventy of coronary artery lesions in postmenopausal. Chin J Interv Cardiol (Chin) 2007; 15: 26-30.
20. Wang H, Chen DY, Cao J, He ZY, Zhu BP, Long M. High serum resistin level may be an indicator of the severity of coronary disease in acute coronary syndrome. Chin Med Sci J 2009;24:161-166.
21. Lubos E, Messow CM, Schnabel R, Rupprecht HJ, Espmola-Klem C, Bickel C, et al. Resistin, acute coronary syndrome and prognosis results from atherogene study. Atherosclerosis 2007; 193: 121-128.
22. Al-Daghn N, Chetty R, McTernan PG, Al-Rubean K, Al-Attas O, Jones AF, et al. Serum resistin is associated with C-reactive protein and LDL cholesterol in type 2 diabetes and coronary artery disease in a Saudi population. Cardiovasc Diabetol2005;4:10.
23. Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD, et al. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 2003; 108: 736-740.
24. Dibra A, Mehilh J, Braun S, Hadamitzky M, Baum H, Dirschmger J, et al. Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting. Am J Med 2003; 114: 715-722.
25. Adamsson Eryd S, Smith JG, Melander O, Hedblad B, Engström G Incidence of coronary events and case fatality rate in relation to blood lymphocyte and neutrophil counts. Arterioscler Thromb Vasc Biol 2012; 32: 533-539.
26. Calabro P, Samudio I, Willerson JT, Yeh ET. Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation 2004; 110: 3335-3340.